ZNTL ZENTALIS PHARMACEUTICALS INC Management Changes 8-K Filing 2024 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Melissa Epperly resigned as Chief Financial Officer of Zentalis Pharmaceuticals, Inc. and Cam Gallagher was appointed as interim CFO.Get access to all SEC 8-K filings of the ZENTALIS PHARMACEUTICALS INC